ADVERTISEMENT
Oxcarbazepine Use, Choosing an Atypical Antipsychotic in Bipolar Treatment
In a recent live Q&A session at the virtual Psych Congress Regionals, Psych Congress Steering Committee Member, Gregory Mattingly, MD, answers audience questions regarding bipolar disorder treatment. Dr Mattingly shares tips on choosing between atypical antipsychotics and what place oxcarbazepine and carbamazepine have in the treatment of bipolar disorder.
To register for the next Psych Congress Regionals meeting in your time zone, visit the meeting website.
Gregory Mattingly, MD, is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St Charles Psychiatric Associates. He earned his medical degree at Washington University. Dr Mattingly is a diplomat of the National Board of Medical Examiners. He is an associate clinical professor at Washington University where he teaches psychopharmacology courses for third-year medical students. Dr Mattingly has been a principal investigator in over 200 clinical trials. Dr Mattingly currently serves as the President-Elect for The American Professional Society of ADHD and Related Disorders and is a certified evaluator for the NFL regarding ADHD and head concussions. He also serves on the board of Headway House, a community support program for individuals with chronic mental illness.
